Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,256
Closed -$867K 115
2026
Q1
$867K Sell
7,256
-146
-2% -$19.1K 0.21% 91
2025
Q4
$1.01M Buy
7,402
+82
+1% +$11.8K 0.24% 92
2025
Q3
$1.08M Buy
7,320
+99
+1% +$13.7K 0.26% 94
2025
Q2
$934K Buy
+7,221
New +$875K 0.25% 96
2025
Q1
Sell
-6,794
Closed -$788K 119
2024
Q4
$788K Buy
6,794
+37
+0.5% +$4.68K 0.24% 98
2024
Q3
$912K Sell
6,757
-755
-10% -$101K 0.29% 91
2024
Q2
$1.02M Buy
7,512
+98
+1% +$13.3K 0.3% 88
2024
Q1
$958K Buy
+7,414
New +$896K 0.29% 88
2019
Q3
$217K Sell
2,780
-296
-10% -$23.3K 0.13% 109
2019
Q2
$247K Buy
+3,076
New +$245K 0.16% 106

Other funds holding XYL

SWS Partners's XYL Position: Q2 2026 in Review

SWS Partners sold out of Xylem (XYL) in Q2 2026, closing a stake of 7,256 shares — an estimated $867K sold.

SWS Partners first reported a position in XYL in Q2 2019 and held it in 10 quarters. The position peaked at $1.08M in Q3 2025. 504 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • SWS Partners reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • SWS Partners sold 7,256 Xylem shares in Q2 2026, an estimated $867K.
  • SWS Partners first reported a position in Xylem in Q2 2019 and held it in 10 quarters.
  • SWS Partners's Xylem position peaked at $1.08M in Q3 2025.
  • 504 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on SWS Partners's 13F filing for Q2 2026, filed 3 Aug 2026.